An evaluation of two new haemagglutination tests for the rapid diagnosis of autoimmune thyroid diseases

Similar documents
Evaluation of a tanned red cell technique for thyroid microsomal antibodies

AUTOIMMUNE RESPONSES TO HUMAN TUMOUR ANTIGENS

Diagnostic tests for thyroid antibodies: A comparison of the precipitin and latex-fixation (Hyland TA1) tests

See external label 2 C-8 C = C-REACTIVE PROTEIN (CRP) LATEX SLIDE TEST

Treponema pallidum immune adherence test for

of thyroid disease A latex particle precipitation test in the diagnosis N/l NaOH/litre and with 10% citric acid. This ph was

for detecting antibody to hepatitis B virus core antigen

Autoantibodies in childhood connective tissue diseases

heteroagglutinins in human sera applicable to rubella haemagglutination inhibition testing at low dilutions

Effective Date: 09/08 Supersedes Revision/Date: Original Revision: 09/08 Date Adopted:

Chronic immune colitis in rabbits

STUDIES OF THE HEMAGGLUTININ OF HAEMOPHILUS PERTUSSIS HIDEO FUKUMI, HISASHI SHIMAZAKI, SADAO KOBAYASHI AND TATSUJI UCHIDA

Measuring IgG anti-a/b titres using dithiothreitol (DTT)

however, and the present communication is concerned with some of

Presented by DR. NUSRAT SIDDIQUA Phase B student. Department of Microbiology & Immunology, BSMMU

Reagents for the Typing of Human Influenza Isolates 2011

antithyroglobulin autoantibodies in human serum

Design Verification. Form:

Secondary fluorescent staining of virus antigens by rheumatoid factor and fluorescein-conjugated anti-lgm

See external label 96 tests HSV 2 IgA. Cat #

This product was developed by the Victorian Infectious Diseases Reference Laboratory (VIDRL) in its capacity as a WHO Collaborating Centre for

(For In Vitro Diagnostic Use)

RG12T. For In Vitro Diagnostic Use. Passive Particle-Agglutination Test for Detection of Antibodies to HTLV-

REAGENTS FOR THE TYPING OF HUMAN INFLUENZA ISOLATES 2017

The Behaviour of Tanned Erythrocytes in Various Haemagglutination Systems

A stable haemagglutinating antigen for detecting toxoplasma antibodies

Rubella Latex Agglutination Test

IVD information *Droppers for the sensitized and control cells. Not for use other than dispensing the sensitized and control cells.

family history of thyroid disease. No correlation was found between the

(From the Department of Pathology, New York University, School of Medicine, and The Rockefeller Institute, New York)

Freeze-Dried Erythrocytes for an Indirect Hemagglutination Test for Detection of Cytomegalovirus Antibodies

Use of Trypsin-Modified Human Erythrocytes

To detect antibodies to Avian Influenza (AI) using the haemagglutination inhibition test in avian serum specimens 2.

Syphilis. sera from the Venereal Disease Serology Laboratory. Serum Bank, Centers for Disease Control, Atlanta,

Herpes Simplex Virus 2 IgM HSV 2 IgM

Serological studies on 40 cases of mumps virus

Instructions for Use. Tg Antibody ELISA

Anti-TSH-Receptor ELISA

Mycoplasma pneumoniae IgG ELISA Kit

Antibodies to Treponema pallidum

Issued by: LABORATORY MANAGER Original Date: March 20, 2000 Approved by: Laboratory Director Revision Date: July 26, 2000 CRYPTOCOCCAL ANTIGEN

Thyroid Peroxidase IgG ELISA Kit

Herpes Simplex Virus 2 IgG HSV 2 IgG

an antirubella antibody labelled with iodine-125 not require purified rubella antigen and, in general, are resistant to false positive results due to

Thyroid Peroxidase IgG ELISA

Application of a screening test for antibody

Astrovirus-associated gastroenteritis in children

Effective Date: 01/07 Supersedes Revision/Date: 01/02 Revision: 01/07 Date Adopted:

Laboratory Procedure Handout RHEUMATOID FACTORS

FIXATION, "6RA-TEST," AND BENTONITE FLOCCULATION TESTS

TSH Receptor Autoantibody ELISA

Antimicrosomal Antibodies, Gastric Parietal Cell Antibodies and Antinuclear Factors in Insulin Dependent Diabetes Mellitus

Cryptococcal Antigen Latex Agglutination Test

SURVIVAL AFTER TRANSFUSION OF Rh-POSITIVE ERYTHROCYTES PREVIOUSLY INCUBATED

ELEGANCE Chlamydia pneumoniae IgG ELISA KIT

SEROLOGICAL DIAGNOSIS OF VIRAL INFECTIONS:

Evaluation of a New Rapid Plasma Reagin Card Test as a Screening Test for Syphilis

THE CYTOPATHOGENIC ACTION OF BLUETONGUE VIRUS ON TISSUE CULTURES AND ITS APPLICATION TO THE DETECTION OF ANTIBODIES IN THE SERUM OF SHEEP.

DIAGNOSTIC AUTOMATION, INC.

Human Thyroid-Peroxidase Antibody, TPO-Ab ELISA Kit

Toxoplasma gondii IgM (Toxo IgM)

CYTOMEGALOVIRUS (CMV) IgM ELISA Kit Protocol

Campylobacter like organisms on the gastric mucosa:

Mouse C3 (Complement Factor 3) ELISA Kit

C for 2 hr at 22,620 X G. The supernatant fluid. was discarded and the sediment resuspended to

(From the Laboratories of the International Health Division of The Rockefeller Foundation, New York)

HSV-1 IgM ELISA. Catalog No (96 Tests) For Research Use Only. Not for use in Diagnostic Procedures.

PNEUMOCOCCUS VALENT LATEX KIT

Chlorphenesin: an Antigen-Associated Immunosuppressant

Pandemic Preparedness Team Immunology and Pathogenesis Branch Influenza Division Centers for Disease Control and Prevention USA VERSION 1

See external label 2 C-8 C 96 tests Chemiluminescence. CMV IgM. Cat # Diluted samples, controls & calibrator 100 µl 30 minutes

J07 Titer dynamics, complement fixation test and neutralization tests

untreated and treated syphilis

Human Thyroglobulin EIA

Apolipoprotein A-1 ELISA

ORTHO BioVue System Handbook

CHAPTER 4 RESULTS 42

Syphilis (TPA) IgG ELISA kit

Human Cytomegalovirus IgM ELISA Kit

HIV-1 p24 ANTIGEN CAPTURE ASSAY

Direct immunofluorescence of skin using formalin-fixed paraffin-embedded sections

HBsAg CONFIRMATORY TEST

Prothrombin (Human) ELISA Kit

Identification of Microbes Lecture: 12

Syphilis. syphilis. Sera from all stages of syphilis and the. to compare dilution titers with those obtained

H.Pylori IgG

Treponema pallidum IgM ELISA Kit

Treponema Pallidum Total Antibody ELISA

H.Pylori IgG Cat # 1503Z

Instructions for Use. IA2 Antibody ELISA. Enzyme Immuno Assay for the Quantitative Determination of Antibodies against IA-2 in Serum.

See external label 2 C-8 C 96 tests CHEMILUMINESCENCE. CMV IgG. Cat # Step (20-25 C Room temp.) Volume

H.pylori IgA Cat #

IMMUNOLOGIC REACTIVITY IN HUMAN BREAST CANCER AGAINST CULTURED HUMAN BREAST TUMOR CELLS

TSH Receptor Monoclonal Antibody (49) Catalog Number MA3-218 Product data sheet

Human LDL ELISA Kit. Innovative Research, Inc.

VGKC-Autoantibody Assay RIA

Treponema pallidum Total ELISA Kit

TUBERCULOSIS 1. positive while 67 were negative. Thirty-four of the latter. group were entering freshmen students at the University

2 Screen Islet Cell Autoantibody Human ELISA

Transcription:

Journal of Clinical Pathology, 1978, 31, 1147-115 An evaluation of two new haemagglutination tests for the rapid diagnosis of autoimmune thyroid diseases I. CAYZER, S. R. CHALMERS, D. DONIACH', AND G. SWANA1 From The Wellcome Research Laboratories, Beckenham, Kent BR3 3BS and the 'Department of Immunology, Middlesex Hospital Medical School, London WI, UK SUMMARY Two haemagglutination tests using preserved turkey erythrocytes are described for the detection of thyroglobulin and microsomal antibodies, respectively. Comparative studies with the more traditional sheep cell techniques show good correlation of titres when testing sera from patients with autoimmune thyroid disorders. Antibodies to thyroglobulin were first detected by a haemagglutination technique using fresh sheep cells treated with tannic acid (Witebsky and Rose, 1956). The technique was modified (Fulthorpe et al., 1961) using formalin as a preservative to improve the stability of the reagents. Microsomal antibodies have more traditionally been demonstrated by either complement fixation tests or immunofluorescence. More recently, microsomal activity has also been demonstrated by haemagglutination (Fujita and Yamada, 197) using sheep cells coated with human thyroid microsomal proteins isolated from thyroid glands. Although sheep cells have been used reliably for many years, the use of avian cells as the carrier particle would seem to offer advantages of speed and specificity as demonstrated by their application to other HA systems (Sequeira and Eldridge, 1973; Cayzer et al., 1974). The present paper describes the production and evaluation of HA tests for the detection of thyroglobulin and microsomal antibodies using turkey in preference to sheep erythrocytes. Both techniques proved easy to perform and read, giving results within one hour. Material and methods CELLS Turkey erythrocytes were obtained by collecting blood in Alsevers solution and washing in saline by repeated centrifugation. The treatment of the cells with formaldehyde followed essentially the method described by Sequeira and Eldridge (1973). Cells pre- Received for publication 5 June 1978 pared by this technique may be stored as a 1% suspension in saline containing 1 Y% sodium azide at 4C without deterioration for up to six months. THYROGLOBULIN The thyroglobulin for cell sensitisation was isolated from human thyroids by fractionation of a saline extract with ammonium sulphate (Derrien et al., 1948). Excess ammonium sulphate was removed from the partially purified thyroglobulin by dialysis against distilled water. The final preparation was stored frozen until required for sensitisation. MICROSOMAL ANTIGEN Thyroid glands taken from patients with Graves disease were immediately frozen and stored until required. The frozen glands were finely sliced with a scalpel, suspended in -15 M KCI, and homogenised in a Waring blender. The microsomes were separated from other cell debris by differential centrifugation using a modification of the technique described by Amino et al. (1976). After sonication to obtain a soluble microsomal fraction the antigen was stored frozen until required for sensitisation. CELL SENSITISATION The formaldehyde-preserved cells were treated with tannic acid and then sensitised with either the thyroglobulin or microsomal antigen preparation. The levels of antigen that were required for sensitisation were determined by preliminary experiments covering a range of different antigen concentrations. The optimum proportions of cells and antigens were those which gave maximum sentivity when titrated against sera known to contain the corresponding 1147 J Clin Pathol: first published as 1.1136/jcp.31.12.1147 on 1 December 1978. Downloaded from http://jcp.bmj.com/ on 22 July 218 by guest. Protected by

1148 antibodies, while at the same time retaining clarity of sedimentation patterns. Unsensitised 'control' cells were prepared in the same manner, omitting the procedure of antigen sensitisation. For long-term stability, test and control cells were preserved by lyophilisation. SAMPLE DILUENTS Thyroglobulin The diluent used for titrating serum samples to be tested with the thyroglobulin-coated cells was isotonic saline containing 1 % normal turkey serum. Microsome In addition to normal turkey serum the microsomal cell diluent contained 1 mg/ml of a preparation of human thyroglobulin. TEST PROCEDURES Both haemagglutination tests were carried out using microtitration apparatus with rigid U-welled plates. For the thyroglobulin HA test, unheated serum samples were titrated in doubling dilutions using standard -25 ml volumes starting at a dilution of 16384 (1282) 496- (642) 124 (322) 256 (162) 6 64- u (8 ) aj 16- _ (42) Q 4- a, (22) -C L 1 - (12) A 4L Cayzer, S. R. Chalmers, D. Doniach, and G. Swana 1:1. To each -25 ml of diluted serum was added -25 ml of sensitised cells. A control for each serum was included at a dilution of 1:1 by adding -25 ml of unsensitised cells. The microsomal HA test was performed by making fourfold dilutions of serum inactivated at 56C for 3 minutes, starting at a dilution of 1:1. To each -75 ml of diluted serum was added -25 ml of sensitised cells. Similarly, a control for each serum using unsensitised cells was included at the 1:1 dilution level. To evaluate the sensitivity and specificity of the two tests, samples were also tested by established, commercially available sheep cell reagents (Thyroglobulin Haemagglutination Test Kit from Wellcome Reagents, Beckenham, Kent; Microsome HA prepared by Fujizoki Pharmaceutical Co Ltd, Japan). The Microsome HA test was also compared with the indirect immunofluorescence technique, using thyrotoxic thyroid glands as substrate. Test sera were applied for 2 minutes at room temperature followed by anti-human-fab/fitc conjugate with 2 x 2 minute washes before and after the conjugate. Positive results obtained with undiluted test sera were subsequently titrated using serial serum dilutions starting at 1:1. A little over 4 test samples were examined by the * A A o. A _ *S A A2D AO- Abe OD I I I I 1 4 16 64 Turkey cell reciprocal titre (x1). *. I I I 11 256 124 496 16384 Fig. 1 Comparison of turkey and sheep cell haemagglutination titres for thyroglobulin antibody in 158 sera: Hashimoto (A); myxoedema (); thyrotoxicosis (). J Clin Pathol: first published as 1.1136/jcp.31.12.1147 on 1 December 1978. Downloaded from http://jcp.bmj.com/ on 22 July 218 by guest. Protected by

An evaluation of two new haemagglutination tests for the rapid diagnosis of autoimmune thyroid diseases 1149 ) L- U -1 1 485 76-2 621 44. 655 36-163 84-4 96 - *m~ * 'L A* I -I t I I I I I I I I I I I I I * ai N) Vpj hi 'if 4<7 Turkey cell reciprocal t itre above methods. The samples were of the following origin: 43 sera from patients diagnosed as goitrous thyroiditis (Hashimoto's disease); 7 sera from patients with atrophic thyroiditis (myxoedema); 45 sera from patients with thyrotoxicosis (Graves/ Basedow disease); 32 miscellaneous sera from patients with various autoimmune thyroid disorders (tested by the microsomal HA systems only); and 19 sera from normal blood donors tested as controls. Results 124. 2 56-64* 16. 4-1. AC AVB.Aomo Both turkey cell systems correlated well with commercially available sheep cell tests. Figure 1 shows the results of the thyroglobulin titrations comparing the turkey cell method with the sheep cell technique of Fulthorpe. The titration systems were identical for both reagents, although the two tests were performed on o A A AP......... a a a a w m m "IsI"5X a Fig. 2 Comparison of turkey and sheep cell haemagglutination titres for microsomal antibody in 19 sera: Hashimoto (A); myxoedema (*); thyrotoxicosis (). separate occasions in different laboratories. Sera that gave titres in excess of 1:512 were retested at higher dilutions to ensure a quantitative result. Satisfactory agreement was also found when comparing the microsomal turkey cells with the Fujizoki sheep cell haemagglutination test kit (Fig. 2). The latter method was performed according to the manufacturer's instructions using cells freshly reconstituted on the day of test. The results are expressed as the (square root)2 of the total reaction volume in the microtitre well. We have preferred to report our results on the turkey cell test as the dilution of the serum before the addition of cells. There was good correlation between cytoplasmic immunofluorescence and microsomal haemagglutination titres, taking into account the 1-fold greater sensitivity of the HA test. The comparison between immunofluorescence and microsomal HA was performed on a small selected group of samples covering a wide range of antibody titres. The correlation between the two test systems is shown in Fig. 3 and shows good agreement at all levels. I J Clin Pathol: first published as 1.1136/jcp.31.12.1147 on 1 December 1978. Downloaded from http://jcp.bmj.com/ on 22 July 218 by guest. Protected by

115 Ln > 128-64- 32-16- Z 8- (U 8 4- Un o + 2 E 1. 1 NEG..' m S U.. I. m 1. Cayzer, S. R. Chalmers, D. Doniach, and G. Swana I * * I I I I I NEG. 1 4 16 E54 256 124 496 16384 Microsomal HA titres (x1) Both test systems gave negative results with the majority of normal donors tested. The positive results obtained were generally of low titre, as might be expected in a small random population (Table). Table Positive results obtained with samples from 19 blood donors Thyroglobulin titres <1:1 1:1 1:2 1:16 1:64 No. of sera 173 1 4 1 1 Microsomal titres <1:1 1:1 1 :4 1:16 No. of sera 177 2 8 3 Among the 16 positive sera (8 5 %), nine contained microsomal antibody only, three thyroglobulin antibody only, and four contained both antibodies. Discussion The thyroglobulin haemagglutination test has for many years been accepted as a simple reliable system for the detection of thyroglobulin antibodies. When used in conjunction with the more recently developed microsomal HA test system, results give useful predictive evidence of thyroid dysfunction in patients with a wide range of autoimmune diseases. The application of turkey cells to passive HA tests has considerably reduced both the Fig. 3 Correlation between turkey cell haemagglutination and immunofluorescence for nicrosomal antibody. incidence of non-specific agglutination and the time taken for the cells to sediment, permitting results to be read in less than one hour. These factors have been used to good advantage in both of the test systems described. The incidence of nonspecific results due to turkey cell agglutinins reacting with unsensitised control cells was less than 1 % when a normal population of blood donors was tested. However the number of nonspecific reactions increased dramatically when sera were tested that were not clear and free from bacterial contamination. During the preparation of microsomal antigen for cell sensitisation thyroglobulin is often carried over at the same time. The resultant reagent is very likely to give false-positive results with sera containing high-titre antibodies to thyroglobulin. To overcome this difficulty, free thyroglobulin has been added to the microsomal HA diluent. Although the number of normal donors tested was small, the frequency of positive results (microsomal 7%, thyroglobulin 4Y) correlates well with data available on the prevalence of thyroid antibodies in the normal population (Tunbridge et al., 1977). When comparing the titres observed in the three autoimmune thyroid disorders studied, the expected J Clin Pathol: first published as 1.1136/jcp.31.12.1147 on 1 December 1978. Downloaded from http://jcp.bmj.com/ on 22 July 218 by guest. Protected by

An evaluation of two new haemagglutination tests for the rapid diagnosis ofautoimmune thyroid diseases 1151 spread of results was found. Approximately 45 % of all Hashimoto sera had high titres (in excess of 1:512) for thyroglobulin antibodies whereas only 5% of thyrotoxic patients reached such levels. With both microsomal and thyroglobulin tests the sera from the thyrotoxic patients gave the highest proportion of negative results among the samples from patients with known thyroid disease. References Amino, N., Hagen, S. R., Yamada, N., and Refetoff, S. (1976). Measurement of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: its usefulness in the diagnosis of autoimmune thyroid diseases. Clinical Endocrinology, 5, 115-125. Cayzer, I., Dane, D. S., Cameron, C. H., and Denning, J. V. (1974). A rapid haemagglutination test for hepatitis-b antigen. Lancet, 1, 947-949. Derrien, Y., Michel, R., and Roche, J. (1948). Recherches sur la preparation et les propri6tes de la thyroglobuline pure. I. Biochimica et Biophysica Acta, 2, 454-47. Fujita, K., and Yamada, N. (197). Haemagglutination test utilizing the microsomal antigen from thyroid epithelial cells. Clinical Pathology (Japan), 18, 213-218. Fulthorpe, A. J., Roitt, I. M., Doniach, D., and Couchman, K. (1961). A stable sheep cell preparation for detecting thyroglobulin autoantibodies and its clinical applications. Journal of Clinical Pathology, 14, 645-66. Sequeira, P. J. L., and Eldridge, A. E. (1973). Treponemal haemagglutination test. British Journal of Venereal Diseases, 49, 242-248. Tunbridge, W. M. G., Evered, D. C., Hall, R., Appleton, D., Brewis, M., Clark, F., Grimley Evans, J., Young, E., Bird, T., and Smith, P. A. (1977). The spectrum of thyroid disease in a community: the Whickham survey. Clinical Endocrinology, 7, 481-493. Witebsky, E., and Rose, N. R. (1956). Studies on organ specificity. IV. Production of rabbit thyroid antibodies in the rabbit. Journal of Immunology, 76, 48-416. Requests for reprints to: 1. Cayzer, Wellcome Research Laboratories, Beckenham, Kent BH3 3BS J Clin Pathol: first published as 1.1136/jcp.31.12.1147 on 1 December 1978. Downloaded from http://jcp.bmj.com/ on 22 July 218 by guest. Protected by